Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accuracy, aforementioned, appendage, atrial, attend, brain, CAS, CASMED, cloud, conversion, covert, curtailed, curtailment, dedesignated, differentiated, discover, earliest, Evalve, EW, expert, exploit, fabricated, footnote, footprint, Gallen, hosted, hosting, impersonation, inception, intelligent, IPRM, iv, ix, malware, network, nursing, overhead, overpayment, owed, personal, pertinent, pivotal, postretirement, proficiency, protocol, ratably, RELILIA, repaid, repay, restore, reversal, reversed, routinely, sabotage, scaling, Shannon, standalone, subtotal, symbol, terrorist, TMTT, unintentional, unsatisfied, upward, vandalism, vi, vii, viii, visibility, xi, xii
Removed:
accelerate, assertion, assigning, assured, biopharmaceutical, broaden, complaint, converting, deduction, deficiency, developer, dysfunction, earned, entering, expansion, factor, fieldwork, finalized, industrial, ineffective, list, matter, Medizintechnik, obligated, Office, paravalvular, partnership, pioneered, prosthetic, PVT, restatement, Sadra, Scimed, sealing, sizable, stage, suspense, title, transferring, unmet, ventricular, weakening
Filing tables
Filing exhibits
Related press release
Associated EW transcripts
EW similar filings
Filing view
External links
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, and 333-217909) and Form S-3 (No. 333-213358) of Edwards Lifesciences Corporation of our report dated February 15, 2019 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Irvine, California
February 15, 2019